Literature DB >> 21107261

Cataract surgery in developing countries.

Rohit Khanna1, Siddharth Pujari, Virender Sangwan.   

Abstract

PURPOSE OF REVIEW: To review the previous year's literature related to cataract surgery in developing countries and to provide fast, up-to-date information to the scientific world. RECENT
FINDINGS: Cataract is the leading cause of blindness, especially in developing countries. The prevalence of cataract increases with the aging population. Although cataract surgery is the most cost-effective intervention, its delivery in developing countries has many issues and challenges. A paradigm shift has occurred in the surgical techniques used for delivering cataract services and the outcomes have been positive in some countries compared to the scenario a decade ago. However, in some parts of Africa, it still continues to be a challenge. Apart from this, the issues related to ongoing supply of consumables and human resources continue to be a challenge in these countries.
SUMMARY: Although manual small incision cataract surgery is the most cost-effective intervention, there are other issues related to the delivery of services in developing countries. We need to plan a comprehensive strategy to deliver the services in developing countries if we want to achieve our goal of VISION 2020.

Entities:  

Mesh:

Year:  2011        PMID: 21107261     DOI: 10.1097/ICU.0b013e3283414f50

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  27 in total

Review 1.  Phototoxicity of environmental radiations in human lens: revisiting the pathogenesis of UV-induced cataract.

Authors:  Farzin Kamari; Shahin Hallaj; Fatemeh Dorosti; Farbod Alinezhad; Negar Taleschian-Tabrizi; Fereshteh Farhadi; Hassan Aslani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-21       Impact factor: 3.117

2.  Cataract management in Ebola virus disease survivors: clinical and scientific implications.

Authors:  Alexa L Li; Duncan E Berry; Jessica G Shantha; Steven Yeh
Journal:  Future Virol       Date:  2019-01-21       Impact factor: 1.831

3.  Effects of phacoemulsification with versus without viscoelastic devices on surgical outcomes.

Authors:  İbrahim Taşkın; Lokman Aslan
Journal:  Int Ophthalmol       Date:  2017-05-09       Impact factor: 2.031

4.  The Barrie Jones Lecture-Eye care for the neglected population: challenges and solutions.

Authors:  G N Rao
Journal:  Eye (Lond)       Date:  2015-01       Impact factor: 3.775

5.  A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract.

Authors:  Le Ma; Zhen-xuan Hao; Ru-ru Liu; Rong-bin Yu; Qiang Shi; Jian-ping Pan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-23       Impact factor: 3.117

6.  Comparison of surgically induced astigmatism in various incisions in manual small incision cataract surgery.

Authors:  Nidhi Jauhari; Deepak Chopra; Rajan Kumar Chaurasia; Ashutosh Agarwal
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

7.  Incidence of Pseudophakic Cystoid Macular Oedema Post-Cataract Surgery in Illawarra Shoalhaven Local Health District, Australia.

Authors:  Ishith Seth; Gabriella Bulloch; Alvin Tan; Erin Thornell; Smita Agarwal
Journal:  Biomed Hub       Date:  2022-01-18

Review 8.  Intraocular lens optic edge design for the prevention of posterior capsule opacification after cataract surgery.

Authors:  Sophie Maedel; Jennifer R Evans; Annette Harrer-Seely; Oliver Findl
Journal:  Cochrane Database Syst Rev       Date:  2021-08-16

9.  Primary posterior capsular opacification in Indian rural population undergoing cataract surgery for hypermature senile cataract.

Authors:  Rajesh Subhash Joshi
Journal:  Clin Ophthalmol       Date:  2013-08-08

Review 10.  Elimination of avoidable blindness due to cataract: where do we prioritize and how should we monitor this decade?

Authors:  Gudlavalleti V S Murthy; Neena John; Bindiganavale R Shamanna; Hira B Pant
Journal:  Indian J Ophthalmol       Date:  2012 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.